Literature DB >> 19399407

The inhibitory effect of astilbin on the arteriosclerosis of murine thoracic aorta transplant.

Jinping Zhao1, Ping Li, Yunfeng Zhang, Xianguo Wang, Qilin Ao, Sihai Gao.   

Abstract

The inhibitory effect of astilbin on transplant arteriosclerosis in murine model of thoracic aorta transplantation was examined. Model of rat thoracic aorta transplantation was established. Ninety rats were divided into three groups. In isograft group, the thoracic aorta of Brown Norway (BN) rat was anastomosed with the abdominal aorta of another BN rat. In allograft group, the thoracic aorta of BN rat was anastomosed with the abdominal aorta of Lewis rat. In astilbin group, the rats receiving allo-transplantation were given astilbin 5 mg/kg per day for a time of 28 days. The donor thoracic aorta and the recipient abdominal aorta were anastomosed by means of a polyethylene cannula (inner diameter: 1.5 mm, length: 3 mm length). The grafts were histologically examined for structural changes. The areas of arterial lumen and endatrium were calculated. Our results showed that, in the allograft group, 28 days after allografting, conspicuous proliferation of smooth muscles and infiltration with a great number of inflammatory cells were found in the tunica intima and tunica media. Astilbin significantly inhibited the proliferation of smooth muscles and ameliorated the infiltration of inflammatory cells thereby prevent against the development of transplant arteriosclerosis. It is concluded that asltilbin can effectively prevent the development of arteriosclerosis in allotransplant by inhibiting the proliferation of smooth muscles and inhibit the proliferation of smooth muscles in tunica of intima and media and reducing infiltration of the inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399407     DOI: 10.1007/s11596-009-0215-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.

Authors:  K Teranishi; R S Poston; B A Reitz; R C Robbins
Journal:  Transplant Proc       Date:  1998-06       Impact factor: 1.066

2.  Astilbin selectively facilitates the apoptosis of interleukin-2-dependent phytohemagglutinin-activated Jurkat cells.

Authors:  R Yan; Q Xu
Journal:  Pharmacol Res       Date:  2001-08       Impact factor: 7.658

3.  Norepinephrine-augmenting lipolytic effectors from Astilbe thunbergii rhizomes.

Authors:  L K Han; H Ninomiya; M Taniguchi; K Baba; Y Kimura; H Okuda
Journal:  J Nat Prod       Date:  1998-08       Impact factor: 4.050

4.  Astilbin suppresses delayed-type hypersensitivity by inhibiting lymphocyte migration.

Authors:  Yu Cai; Ting Chen; Qiang Xu
Journal:  J Pharm Pharmacol       Date:  2003-05       Impact factor: 3.765

5.  Astilbin suppresses collagen-induced arthritis via the dysfunction of lymphocytes.

Authors:  Y Cai; T Chen; Q Xu
Journal:  Inflamm Res       Date:  2003-08       Impact factor: 4.575

6.  Donor-transmitted coronary atherosclerosis.

Authors:  Onnen Grauhan; Johannes Patzurek; Manfred Hummel; Hans Lehmkuhl; Michael Dandel; Miralem Pasic; Yuguo Weng; Roland Hetzer
Journal:  J Heart Lung Transplant       Date:  2003-05       Impact factor: 10.247

Review 7.  Immunosuppression and transplant vascular disease: benefits and adverse effects.

Authors:  Farzad Moien-Afshari; Bruce M McManus; Ismail Laher
Journal:  Pharmacol Ther       Date:  2003-11       Impact factor: 12.310

8.  Enhancement of the vanadate-stimulated release of lipoprotein lipase activity by astilbin from the leaves of Engelhardtia chrysolepis.

Authors:  T Motoyashiki; M Miyake; T Morita; K Mizutani; H Masuda; H Ueki
Journal:  Biol Pharm Bull       Date:  1998-05       Impact factor: 2.233

  8 in total
  3 in total

1.  Astilbin inhibits proliferation of rat aortic smooth muscle cells induced by angiotensin II and down-regulates expression of protooncogene.

Authors:  Ping Li; Sihai Gao; Wei Jie; Qilin Ao; Yafei Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

2.  Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1.

Authors:  Shizhen Ding; Guotao Lu; Biying Wang; Jie Xiang; Chunxia Hu; Zhijie Lin; Yanbing Ding; Weiming Xiao; Weijuan Gong
Journal:  Front Pharmacol       Date:  2022-05-16       Impact factor: 5.988

3.  Studies on isozymic variation among the South Indian species of Sphaerostephanos.

Authors:  Irudayaraj Varaprasadham; Johnson Marimuthu
Journal:  Asian Pac J Trop Biomed       Date:  2011-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.